{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:42:31Z","timestamp":1790484151612,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>Cardiovascular infections are serious disease associated with high morbidity and mortality. Their diagnosis is challenging, requiring a proper management for a prompt recognition of the clinical manifestations, and a multidisciplinary approach involving cardiologists, cardiothoracic surgeons, infectious diseases specialist, imagers, and microbiologists. Imaging plays a central role in the diagnostic workout, including molecular imaging techniques. In this setting, two different strategies might be used to image infections: the first is based on the use of agents targeting the microorganism responsible for the infection. Alternatively, we can target the components of the pathophysiological changes of the inflammatory process and\/or the host response to the infectious pathogen can be considered. Understanding the strength and limitations of each strategy is crucial to select the most appropriate imaging tool.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>Currently, multislice computed tomography (MSCT) and nuclear imaging (<jats:sup>18<\/jats:sup>F-fluorodeoxyglucose positron emission tomography\/computed tomography, and leucocyte scintigraphy) are part of the diagnostic strategies. The main role of nuclear medicine imaging (PET\/CT and SPECT\/CT) is the confirmation of valve\/CIED involvement and\/or associated perivalvular infection and the detection of distant septic embolism. Proper patients\u2019 preparation, imaging acquisition, and reconstruction as well as imaging reading are crucial to maximize the diagnostic information.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>In this manuscript, we described the use of molecular imaging techniques, in particular WBC imaging, in patients with infective endocarditis, cardiovascular implantable electronic device infections, and infections of composite aortic graft, underlying the strength and limitations of such approached as compared to the other imaging modalities.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11886-022-01708-2","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T12:22:43Z","timestamp":1655122963000},"page":"879-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Alternative Nuclear Imaging Tools for Infection Imaging"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0058-7377","authenticated-orcid":false,"given":"Paola Anna","family":"Erba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Sollini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berchiolli","family":"Raffaella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Zanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esposito","family":"Enrica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lazzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"issue":"1","key":"1708_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jama.288.1.75","volume":"288","author":"B Hoen","year":"2002","unstructured":"Hoen B, Alla F, Selton-Suty C, B\u00e9guinot I, Bouvet A, Brian\u00e7on S, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288(1):75\u201381.","journal-title":"JAMA"},{"key":"1708_CR2","unstructured":"\u2022 Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019. This prospective observational study provides the most up to date on the epidemiological and clinical profile as well as the management and outcomes of patients with infective endocarditis."},{"key":"1708_CR3","doi-asserted-by":"crossref","unstructured":"Berisha B, Ragnarsson S, Olaison L, Rasmussen M. Microbiological aetiology in prosthetic valve endocarditis: a nationwide registry study. J Intern Med. 2022.","DOI":"10.1111\/joim.13491"},{"issue":"12","key":"1708_CR4","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/europace\/eux387","volume":"20","author":"N Cl\u00e9menty","year":"2018","unstructured":"Cl\u00e9menty N, Carion PL, L\u00e9otoing L, Lamarsalle L, Wilquin-Bequet F, Brown B, et al. Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study. Europace. 2018;20(12):1974\u201380.","journal-title":"Europace"},{"issue":"5","key":"1708_CR5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s15010-021-01634-5","volume":"49","author":"JM Urien","year":"2021","unstructured":"Urien JM, Camus C, Leclercq C, Dejoies L, et al. The emergence of Staphylococcus aureus as the primary cause of cardiac device-related infective endocarditis. Infection. 2021;49(5):999\u20131006.","journal-title":"Infection"},{"issue":"10","key":"1708_CR6","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jacc.2011.04.033","volume":"58","author":"AJ Greenspon","year":"2011","unstructured":"Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58(10):1001\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"1708_CR7","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1001\/archinternmed.2011.441","volume":"171","author":"MR Sohail","year":"2011","unstructured":"Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011;171(20):1821\u20138.","journal-title":"Arch Intern Med"},{"issue":"12","key":"1708_CR8","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/pace.12748","volume":"38","author":"DH Lee","year":"2015","unstructured":"Lee DH, Gracely EJ, Aleem SY, Kutalek SP, Vielemeyer O. Differences of mortality rates between pocket and nonpocket cardiovascular implantable electronic device infections. Pacing Clin Electrophysiol. 2015;38(12):1456\u201363.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"1708_CR9","doi-asserted-by":"publisher","first-page":"e008280","DOI":"10.1161\/CIRCEP.119.008280","volume":"13","author":"BL Wilkoff","year":"2020","unstructured":"Wilkoff BL, Boriani G, Mittal S, Poole JE, et al. Impact of cardiac implantable electronic device infection: a clinical and economic analysis of the WRAP-IT Trial. Circ Arrhythm Electrophysiol. 2020;13(5):e008280.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"1708_CR10","doi-asserted-by":"publisher","first-page":"e008280","DOI":"10.1161\/CIRCEP.119.008280","volume":"13","author":"BL Wilkoff","year":"2020","unstructured":"Wilkoff BL, Boriani G, Mittal S, Poole JE, Kennergren C, Corey GR, et al. Impact of cardiac implantable electronic device infection: a clinical and economic analysis of the WRAP-IT Trial. Circ Arrhythm Electrophysiol. 2020;13(5):e008280.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"1708_CR11","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.hrthm.2021.12.013","volume":"19","author":"S Chesdachai","year":"2022","unstructured":"Chesdachai S, Baddour LM, Sohail MR, Palraj BR, et al. Evaluation of European Heart Rhythm Association consensus in patients with cardiovascular implantable electronic devices and Staphylococcus aureus bacteremia. Heart Rhythm. 2022;19(4):570\u20137.","journal-title":"Heart Rhythm"},{"issue":"1","key":"1708_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0001-2092(06)60098-7","volume":"84","author":"C Cherry","year":"2006","unstructured":"Cherry C, DeBord S, Hickey C. The modified Bentall procedure for aortic root replacement. AORN J. 2006;84(1):51\u201370.","journal-title":"AORN J"},{"key":"1708_CR13","doi-asserted-by":"crossref","unstructured":"Lauri C, Signore A, Glaudemans AWJM, Treglia G, et al. Evidence-based guideline of the European Association of Nuclear Medicine (EANM) on imaging infection in vascular grafts. Eur J Nucl Med Mol Imaging. 2022.","DOI":"10.1007\/s00259-022-05769-x"},{"key":"1708_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/2193-1801-3-172","volume":"3","author":"P Tossios","year":"2014","unstructured":"Tossios P, Karatzopoulos A, Tsagakis K, Sapalidis K, Triantafillopoulou K, Kalogera A, et al. Successful surgical in situ treatment of prosthetic graft infection by staged procedure after Bentall operation and total aortic arch replacement. Springerplus. 2014;3:172.","journal-title":"Springerplus"},{"issue":"6","key":"1708_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0002-9343(96)00040-X","volume":"100","author":"PE Fournier","year":"1996","unstructured":"Fournier PE, Casalta JP, Habib G, Messana T, Raoult D. Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med. 1996;100(6):629\u201333.","journal-title":"Am J Med"},{"key":"1708_CR16","doi-asserted-by":"crossref","unstructured":"\u2022 Habib G, Derumeaux G, Avierinos JF, Casalta JP, Jamal F, Volot F, et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol. 1999;33(7):2023\u20139. Results from this study provided a summary of the value and limitations of Duke criteria for the diagnosis of infective endocarditis.","DOI":"10.1016\/S0735-1097(99)00116-3"},{"issue":"3","key":"1708_CR17","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0735-1097(98)00624-X","volume":"33","author":"F Delahaye","year":"1999","unstructured":"Delahaye F, Rial MO, de Gevigney G, Ecochard R, Delaye J. A critical appraisal of the quality of the management of infective endocarditis. J Am Coll Cardiol. 1999;33(3):788\u201393.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1708_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/femsre\/fuy040","volume":"43","author":"E Prudent","year":"2019","unstructured":"Prudent E, Raoult D. Fluorescence in situ hybridization, a complementary molecular tool for the clinical diagnosis of infectious diseases by intracellular and fastidious bacteria. FEMS Microbiol Rev. 2019;43(1):88\u2013107.","journal-title":"FEMS Microbiol Rev"},{"issue":"13","key":"1708_CR19","doi-asserted-by":"publisher","first-page":"e008163","DOI":"10.1161\/JAHA.117.008163","volume":"7","author":"M Abdelghani","year":"2018","unstructured":"Abdelghani M, Nassif M, Blom NA, Van Mourik MS, et al. Infective endocarditis after melody valve implantation in the pulmonary position: a systematic review. J Am Heart Assoc. 2018;7(13):e008163.","journal-title":"J Am Heart Assoc"},{"key":"1708_CR20","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075\u2013128. This guideline provides clear and simple recommendations for the diagnosis and management of patients with IE, assisting healthcare providers in their clinical decision-making.","DOI":"10.1093\/eurheartj\/ehv319"},{"key":"1708_CR21","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, et al. Positron emission tomography\/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61(23):2374\u201382. This study determined that adding abnormal [18F]FDG uptake around the prosthetic valve as a major criterion significantly increased the sensitivity of the modified Duke criteria at admission, significantly reducing the number of possible PVE cases.","DOI":"10.1093\/eurheartj\/eht311.5950"},{"issue":"10","key":"1708_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/eurheartj\/eht274","volume":"35","author":"NE Bruun","year":"2014","unstructured":"Bruun NE, Habib G, Thuny F, Sogaard P. Cardiac imaging in infectious endocarditis. Eur Heart J. 2014;35(10):624\u201332.","journal-title":"Eur Heart J"},{"key":"1708_CR23","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Erba PA, Conti U, Lazzeri E, Sollini M, Doria R, De Tommasi SM, et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT\/CT in the characterization and management of patients with infectious endocarditis. J Nucl Med. 2012;53(8):1235\u201343. This study demonstrates the performances of [99mTc]-HMPAO-WBC scintigraphy and the main clinical benefit of their application to reduce the rate of misdiagnosed cases of IE when combined with standard diagnostic tests.","DOI":"10.2967\/jnumed.111.099424"},{"key":"1708_CR24","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Erba PA, Lancellotti P, Vilacosta I, Gaemperli O, Rouzet F, Hacker M, et al. Recommendations on nuclear and multimodality imaging in IE and CIED infections. Eur J Nucl Med Mol Imaging. 2018;45(10):1795\u2013815. This guideline provides recommendations on how to perform and interpret [18F]FDG PET\/CT and WBC imaging for the diagnosis and management of patients with IE.","DOI":"10.1007\/s00259-018-4025-0"},{"key":"1708_CR25","doi-asserted-by":"crossref","unstructured":"\u2022 Sollini M, Berchiolli R, Delgado Bolton RC, Rossi A, Kirienko M, Boni R, et al. The \u201c3M\u201d approach to cardiovascular infections: Multimodality, Multitracers, and Multidisciplinary. Semin Nucl Med. 2018;48(3):199\u2013224. This review summarizes the use of a Multimodality, Multitracer, and Multidisciplinary approach (the 3M approach) to cardiovascular infections, with particular reference to the role of WBC SPECT\/CT and [18F]FDG PET\/CT and the importance of a Cardiovascular Multidisciplinary Team Approach to select the best test or combination of tests for each specific clinical situation.","DOI":"10.1053\/j.semnuclmed.2017.12.003"},{"issue":"5","key":"1708_CR26","first-page":"e72","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72\u2013227.","journal-title":"Circulation"},{"key":"1708_CR27","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Blomstr\u00f6m-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020;22(4):515\u201349. This consensus document provides clear and simple recommendations for the diagnosis and management of CIED infections, assisting healthcare providers in their clinical decision-making.","DOI":"10.1093\/eurheartj\/ehaa010"},{"issue":"1","key":"1708_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2967\/jnumed.116.181792","volume":"58","author":"AA Ordonez","year":"2017","unstructured":"Ordonez AA, Weinstein EA, Bambarger LE, Saini V, Chang YS, DeMarco VP, et al. A systematic approach for developing bacteria-specific imaging tracers. J Nucl Med. 2017;58(1):144\u201350.","journal-title":"J Nucl Med"},{"issue":"5","key":"1708_CR29","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1021\/acs.jmedchem.9b01623","volume":"63","author":"F Mota","year":"2020","unstructured":"Mota F, Ordonez AA, Firth G, Ruiz-Bedoya CA, et al. Radiotracer development for bacterial imaging. J Med Chem. 2020;63(5):1964\u201377.","journal-title":"J Med Chem"},{"issue":"6","key":"1708_CR30","first-page":"920","volume":"44","author":"L Sarda","year":"2003","unstructured":"Sarda L, Cr\u00e9mieux AC, Lebellec Y, Meulemans A, Lebtahi R, Hayem G, et al. Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med. 2003;44(6):920\u20136.","journal-title":"J Nucl Med"},{"issue":"8996","key":"1708_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0140-6736(96)90407-9","volume":"347","author":"S Vinjamuri","year":"1996","unstructured":"Vinjamuri S, Hall AV, Solanki KK, Bomanji J, Siraj Q, O\u2019Shaughnessy E, et al. Comparison of 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet. 1996;347(8996):233\u20135.","journal-title":"Lancet"},{"issue":"31","key":"1708_CR32","doi-asserted-by":"publisher","first-page":"8372","DOI":"10.1073\/pnas.1703109114","volume":"114","author":"MA Sellmyer","year":"2017","unstructured":"Sellmyer MA, Lee I, Hou C, Weng CC, Li S, Lieberman BP, et al. Bacterial infection imaging with [18F]fluoropropyl-trimethoprim. Proc Natl Acad Sci U S A. 2017;114(31):8372\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1708_CR33","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1021\/acsinfecdis.8b00061","volume":"4","author":"CA Mutch","year":"2018","unstructured":"Mutch CA, Ordonez AA, Qin H, Parker M, Bambarger LE, Villanueva-Meyer JE, et al. [11C]Para-aminobenzoic acid: a positron emission tomography tracer targeting bacteria-specific metabolism. ACS Infect Dis. 2018;4(7):1067\u201372.","journal-title":"ACS Infect Dis"},{"issue":"8","key":"1708_CR34","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1021\/acsinfecdis.0c00374","volume":"6","author":"Y Li","year":"2020","unstructured":"Li Y, Daryaee F, Yoon GE, Noh D, Smith-Jones PM, Si Y, et al. Positron emission tomography imaging of Staphylococcus aureus infection using a nitro-prodrug analogue of 2-[18F] F-p-aminobenzoic acid. ACS Infect Dis. 2020;6(8):2249\u201359.","journal-title":"ACS Infect Dis"},{"issue":"11","key":"1708_CR35","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1021\/acsinfecdis.8b00182","volume":"4","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Ordonez AA, Wang H, Li Y, Gogarty KR, Weinstein EA, et al. Positron emission tomography imaging with 2-[18F]F- p-aminobenzoic acid detects Staphylococcus aureus infections and monitors drug response. ACS Infect Dis. 2018;4(11):1635\u201344.","journal-title":"ACS Infect Dis"},{"issue":"9","key":"1708_CR36","doi-asserted-by":"publisher","first-page":"e107951","DOI":"10.1371\/journal.pone.0107951","volume":"9","author":"G Gowrishankar","year":"2014","unstructured":"Gowrishankar G, Namavari M, Jouannot EB, Hoehne A, Reeves R, Hardy J, et al. Investigation of 6-[18F]-fluoromaltose as a novel PET tracer for imaging bacterial infection. PLoS ONE. 2014;9(9):e107951.","journal-title":"PLoS ONE"},{"issue":"51","key":"1708_CR37","doi-asserted-by":"publisher","first-page":"14096","DOI":"10.1002\/anie.201408533","volume":"53","author":"X Ning","year":"2014","unstructured":"Ning X, Seo W, Lee S, Takemiya K, Rafi M, Feng X, et al. PET imaging of bacterial infections with fluorine-18-labeled maltohexaose. Angew Chem Int Ed Engl. 2014;53(51):14096\u2013101.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"1708_CR38","doi-asserted-by":"publisher","first-page":"7903","DOI":"10.1038\/s41598-017-08415-x","volume":"7","author":"KD Neumann","year":"2017","unstructured":"Neumann KD, Villanueva-Meyer JE, Mutch CA, Flavell RR, Blecha JE, Kwak T, et al. Imaging active infection in vivo using D-amino acid derived PET radiotracers. Sci Rep. 2017;7(1):7903.","journal-title":"Sci Rep"},{"issue":"11","key":"1708_CR39","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1097\/MNM.0b013e32833ce32c","volume":"31","author":"PA Erba","year":"2010","unstructured":"Erba PA, Cataldi AG, Tascini C, Leonildi A, Manfredi C, Mariani G, et al. 111In-DTPA-Biotin uptake by Staphylococcus aureus. Nucl Med Commun. 2010;31(11):994\u20137.","journal-title":"Nucl Med Commun"},{"issue":"259","key":"1708_CR40","doi-asserted-by":"publisher","first-page":"259ra146","DOI":"10.1126\/scitranslmed.3009815","volume":"6","author":"EA Weinstein","year":"2014","unstructured":"Weinstein EA, Ordonez AA, DeMarco VP, Murawski AM, Pokkali S, MacDonald EM, et al. Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med. 2014;6(259):259ra146.","journal-title":"Sci Transl Med."},{"key":"1708_CR41","doi-asserted-by":"crossref","unstructured":"Ordonez AA, Sellmyer MA, Gowrishankar G, Ruiz-Bedoya CA, Tucker EW, Palestro CJ, et al. Molecular imaging of bacterial infections: overcoming the barriers to clinical translation. Sci Transl Med. 2019;11(508).","DOI":"10.1126\/scitranslmed.aax8251"},{"issue":"12","key":"1708_CR42","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/00003072-200412000-00001","volume":"29","author":"AG Vicente","year":"2004","unstructured":"Vicente AG, Almoguera M, Alonso JC, Heffernan AJ, Gomez A, Contreras PI, et al. Diagnosis of orthopedic infection in clinical practice using 99mTc- sulesomab (antigranulocyte monoclonal antibody fragment Fab\u20322). Clin Nucl Med. 2004;29(12):781\u20135.","journal-title":"Clin Nucl Med"},{"issue":"6","key":"1708_CR43","first-page":"582","volume":"54","author":"J Meller","year":"2010","unstructured":"Meller J, Liersch T, Oezerden MM, Sahlmann CO, Meller B. Targeting NCA-95 and other granulocyte antigens and receptors with radiolabeled monoclonal antibodies (Mabs). Q J Nucl Med Mol Imaging. 2010;54(6):582\u201398.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"4","key":"1708_CR44","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00259-010-1393-5","volume":"37","author":"M Roca","year":"2010","unstructured":"Roca M, de Vries EF, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with 111In-oxine. Inflammation\/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37(4):835\u201341.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1708_CR45","unstructured":"SNMMI Procedure Standard for 99mTc Exametazime (HMPAO)-Labeled Leukocyte Scintigraphy for Suspected Infection\/Inflammation 3.0 http:\/\/s3.amazonaws.com\/rdcms-snmmi\/files\/production\/public\/docs\/HMPAO_v3.pdf. Accessed on 24 May 2022"},{"key":"1708_CR46","unstructured":"SNMMI Procedure Standard for 111In-Leukocyte Scintigraphy for Suspected Infection\/Inflammation 3.0 http:\/\/www.snmmi.org\/ClinicalPractice\/content.aspx?ItemNumber=6414#InfecInflamm. Accessed on 24 May 2022"},{"issue":"4","key":"1708_CR47","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s00259-010-1394-4","volume":"37","author":"EF de Vries","year":"2010","unstructured":"de Vries EF, Roca M, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with 99mTc-HMPAO. Inflammation\/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37(4):842\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1708_CR48","first-page":"143","volume":"2020","author":"C Otto","year":"2020","unstructured":"Otto C, Nishimura R, Bonow R, Carabello B, Erwin J, Gentile F, et al. ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;2020:143.","journal-title":"Circulation"},{"key":"1708_CR49","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Erba PA, Sollini M, Conti U, Bandera F, Tascini C, De Tommasi SM, et al. Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections. JACC Cardiovasc Imaging. 2013;6(10):1075\u201386. This study reported the diagnostic performances of [99mTc]-HMPAO-WBC scintigraphy in the largest series of patients with suspected infections associated with cardiovascular implantable electronic devices (CIEDs) currently published in the literature.","DOI":"10.1016\/j.jcmg.2013.08.001"},{"key":"1708_CR50","first-page":"123","volume-title":"Radionuclide imaging of infection and inflammation: a pictorial case-based atlas","author":"PA Erba","year":"2020","unstructured":"Erba PA, et al. Nonorthopedic or cardiovascular implantable device infection. In: Lazzeri E, Signore A, Erba PA, Prandini N, Versari A, D\u2019Errico G, et al., editors. Radionuclide imaging of infection and inflammation: a pictorial case-based atlas. Milano: Springer Milan; 2020. p. 123\u201366."},{"issue":"2","key":"1708_CR51","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00259-013-2582-9","volume":"41","author":"PA Erba","year":"2014","unstructured":"Erba PA, Leo G, Sollini M, Tascini C, Boni R, Berchiolli RN, et al. Radiolabelled leucocyte scintigraphy versus conventional radiological imaging for the management of late, low-grade vascular prosthesis infections. Eur J Nucl Med Mol Imaging. 2014;41(2):357\u201368.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"1708_CR52","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.2967\/jnumed.114.141895","volume":"55","author":"F Rouzet","year":"2014","unstructured":"\u2022 Rouzet F, Chequer R, Benali K, Lepage L, Ghodbane W, Duval X, et al. Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. J Nucl Med. 2014;55(12):1980\u20135. This study showed results from the direct comparison of [18F]FDG PET\/CT and 99mTc-HMPAO-WBC scintigraphy in patients with IE.","journal-title":"J Nucl Med"},{"issue":"2","key":"1708_CR53","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12350-021-02674-y","volume":"29","author":"N Kooshki","year":"2022","unstructured":"Kooshki N, Grambow-Velilla J, Mahida B, Benali K, et al. Diagnostic performance of white blood cell SPECT imaging against intra-operative findings in patients with a suspicion of prosthetic valve endocarditis. J Nucl Cardiol. 2022;29(2):528\u201334.","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"1708_CR54","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10554-018-1487-x","volume":"35","author":"K Holcman","year":"2019","unstructured":"Holcman K, Szot W, Rubi\u015b P, Le\u015bniak-Sobelga A, Hlawaty M, Wi\u015bniowska-\u015amia\u0142ek S, et al. [99mTc]-HMPAO-labeled leukocyte SPECT\/CT and transthoracic echocardiography diagnostic value in infective endocarditis. Int J Cardiovasc Imaging. 2019;35(4):749\u201358.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"1","key":"1708_CR55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4065\/83.1.46","volume":"83","author":"MR Sohail","year":"2008","unstructured":"Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008;83(1):46\u201353.","journal-title":"Mayo Clin Proc"},{"issue":"22","key":"1708_CR56","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.jacc.2012.02.029","volume":"59","author":"X Duval","year":"2012","unstructured":"Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59(22):1968\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1708_CR57","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0735-1097(02)01790-4","volume":"39","author":"I Vilacosta","year":"2002","unstructured":"Vilacosta I, Graupner C, San Rom\u00e1n JA, Sarri\u00e1 C, Ronderos R, Fern\u00e1ndez C, et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol. 2002;39(9):1489\u201395.","journal-title":"J Am Coll Cardiol"},{"key":"1708_CR58","doi-asserted-by":"crossref","unstructured":"\u2022 Juneau D, Golfam M, Hazra S, Zuckier LS, Garas S, Redpath C, et al. Positron emission tomography and single-photon emission Computed tomography imaging in the diagnosis of cardiac implantable electronic device infection: a Systematic Review and Meta-Analysis. Circ Cardiovasc Imaging. 2017;10(4). This is a systematic review of the literature and meta-analysis on the use of [18F]FDG PET\/CT, [99mTc]-HMPAO-WBC, and [67Ga]- citrate in CIED infection.","DOI":"10.1161\/CIRCIMAGING.116.005772"},{"issue":"5","key":"1708_CR59","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/ehjci\/jeu295","volume":"16","author":"FZ Ahmed","year":"2015","unstructured":"Ahmed FZ, James J, Cunnington C, Motwani M, Fullwood C, Hooper J, et al. Early diagnosis of cardiac implantable electronic device generator pocket infection using [18F]FDG-PET\/CT. Eur Heart J Cardiovasc Imaging. 2015;16(5):521\u201330.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"1708_CR60","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jcmg.2015.09.014","volume":"9","author":"S Amraoui","year":"2016","unstructured":"Amraoui S, Tlili G, Sohal M, Berte B, Hindi\u00e9 E, Ritter P, et al. Contribution of PET imaging to the diagnosis of septic embolism in patients with pacing lead endocarditis. JACC Cardiovasc Imaging. 2016;9(3):283\u201390.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"1708_CR61","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1161\/01.CIR.95.8.2098","volume":"95","author":"D Klug","year":"1997","unstructured":"Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997;95(8):2098\u2013107.","journal-title":"Circulation"},{"issue":"3","key":"1708_CR62","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/ejcts\/ezab143","volume":"60","author":"S Rustum","year":"2021","unstructured":"Rustum S, Beckmann E, Martens A, Kr\u00fcger H, et al. Native and prosthetic graft infections of the thoracic aorta: surgical management. Eur J Cardiothorac Surg. 2021;60(3):633\u201341.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"1708_CR63","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/ejcts\/ezw150","volume":"50","author":"J Umminger","year":"2016","unstructured":"Umminger J, Krueger H, Beckmann E, Kaufeld T, et al. Management of early graft infections in the ascending aorta and aortic arch: a comparison between graft replacement and graft preservation techniques. Eur J Cardiothorac Surg. 2016;50(4):660\u20137.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"1708_CR64","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.diagmicrobio.2017.03.002","volume":"88","author":"I Machelart","year":"2017","unstructured":"Machelart I, Greib C, Wirth G, Camou F, Issa N, Viallard JF, et al. Graft infection after a Bentall procedure: a case series and systematic review of the literature. Diagn Microbiol Infect Dis. 2017;88(2):158\u201362.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"1708_CR65","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.36660\/abc.20200706","volume":"116","author":"M Brand\u00e3o","year":"2021","unstructured":"Brand\u00e3o M, Gon\u00e7alves-Teixeira P, Queir\u00f3s PR, Ferreira ND, Oliveira M. Prosthetic aortic valve endocarditis by neisseria elongata after bentall procedure: when multimodality imaging is key to diagnosis. Arq Bras Cardiol. 2021;116(5):1023\u20136.","journal-title":"Arq Bras Cardiol"},{"key":"1708_CR66","doi-asserted-by":"crossref","unstructured":"\u2022 Sollini M, Bartoli F, Boni R, Zanca R, Colli A, Levantino M, et al. Role of multimodal imaging in patients with suspected infections after the Bentall procedure. Front Cardiovasc Med. 2021;8:745556. This study assessed the diagnostic performances of multimodal imaging, [18F]FDG PET\/CT, 99mTc-HMPAO-WBC, in patients with suspected infection after the Bentall procedure, proposing new specific diagnostic criteria for the diagnosis.","DOI":"10.3389\/fcvm.2021.745556"},{"key":"1708_CR67","doi-asserted-by":"crossref","unstructured":"Wahadat AR, Tanis W, Mulders TA, Graven LH, Bekker MWA, Bekkers JA, et al. Normal imaging findings after ascending aorta prosthesis implantation on [18F]-fluorodeoxyglucose positron emission tomography with computed tomography. J Nucl Cardiol. 2021.","DOI":"10.1007\/s12350-021-02826-0"},{"issue":"4","key":"1708_CR68","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.nucmedbio.2008.02.011","volume":"35","author":"M Rusckowski","year":"2008","unstructured":"Rusckowski M, Gupta S, Liu G, Dou S, Hnatowich DJ. Investigation of four (99m)Tc-labeled bacteriophages for infection-specific imaging. Nucl Med Biol. 2008;35(4):433\u201340.","journal-title":"Nucl Med Biol"},{"issue":"1","key":"1708_CR69","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12149-017-1219-7","volume":"32","author":"M Sathekge","year":"2018","unstructured":"Sathekge M, Garcia-Perez O, Paez D, El-Haj N, Kain-Godoy T, Lawal I, et al. Molecular imaging in musculoskeletal infections with 99mTc-UBI 29\u201341 SPECT\/CT. Ann Nucl Med. 2018;32(1):54\u20139.","journal-title":"Ann Nucl Med"},{"key":"1708_CR70","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.nucmedbio.2018.04.003","volume":"62\u201363","author":"J Bhatt","year":"2018","unstructured":"Bhatt J, Mukherjee A, Shinto A, KoramadaiKaruppusamy K, Korde A, Kumar M, et al. Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent. Nucl Med Biol. 2018;62\u201363:47\u201353.","journal-title":"Nucl Med Biol"},{"issue":"1","key":"1708_CR71","doi-asserted-by":"publisher","first-page":"15698","DOI":"10.1038\/s41598-018-33895-w","volume":"8","author":"M Petrik","year":"2018","unstructured":"Petrik M, Umlaufova E, Raclavsky V, Palyzova A, Havlicek V, Haas H, et al. Imaging of Pseudomonas aeruginosa infection with Ga-68 labelled pyoverdine for positron emission tomography. Sci Rep. 2018;8(1):15698.","journal-title":"Sci Rep"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01708-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-022-01708-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01708-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T09:25:58Z","timestamp":1661419558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-022-01708-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1708"],"URL":"https:\/\/doi.org\/10.1007\/s11886-022-01708-2","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"assertion":[{"value":"21 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing Open Access funding information has been added in the Funding Note.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Bartoli reports grants, personal fees, and non-financial support from gammaservizi, and grants from Philogen SpA, outside the submitted work. Dr. Lazzeri reports personal fees from Springer, outside the submitted work. Dr. Erba reports grants and non-financial support from gammaservizi, personal fees from GE Healthcare, grants and personal fees from Philogen SpA, other from AAA, and personal fees from Springer, outside the submitted work. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}